[go: up one dir, main page]

GR20180100568A - Ditanny-based composition against acanthamoeba bacterium affecting the eyes - Google Patents

Ditanny-based composition against acanthamoeba bacterium affecting the eyes Download PDF

Info

Publication number
GR20180100568A
GR20180100568A GR20180100568A GR20180100568A GR20180100568A GR 20180100568 A GR20180100568 A GR 20180100568A GR 20180100568 A GR20180100568 A GR 20180100568A GR 20180100568 A GR20180100568 A GR 20180100568A GR 20180100568 A GR20180100568 A GR 20180100568A
Authority
GR
Greece
Prior art keywords
ditanny
acanthamoeba
bacterium
solution
eyes
Prior art date
Application number
GR20180100568A
Other languages
Greek (el)
Other versions
GR1009779B (en
Inventor
Μαριανα Γεωργιου Χατζαρα
Original Assignee
Μαριανα Γεωργιου Χατζαρα
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Μαριανα Γεωργιου Χατζαρα filed Critical Μαριανα Γεωργιου Χατζαρα
Priority to GR20180100568A priority Critical patent/GR20180100568A/en
Publication of GR1009779B publication Critical patent/GR1009779B/en
Publication of GR20180100568A publication Critical patent/GR20180100568A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14Organic compounds not covered by groups A61L12/10 or A61L12/12
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08Magnoliopsida [dicotyledons]
    • A01N65/22Lamiaceae or Labiatae [Mint family], e.g. thyme, rosemary, skullcap, selfheal, lavender, perilla, pennyroyal, peppermint or spearmint
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

There is disclosed a ditanny-based composition mixed -after proper treatment- with ocular solution. The advantage of the invention is that it is a non-chemical and drug-free composition based on a herb growing in the mountains of Crete and having microbe-neutralizing results proven by experiments conducted in laboratories, in Scotland. In liquid form, it is particularly effective for those who wear contact lenses or swim in pools where the risk of infection is much higher. To combat Acanthamoeba, all we need to do is to add our solution to both, the contact lenses and the storage area thereof. For ideal composition, add 5mg powdered ditanny to 10ml of contact lens preservative ophthalmic solution and mix them to make the final product.

Description

Σύνθεση με βάση το Δίκταμο κατά του βακτηρίου Ακανθαμοέμπα που προσβάλει τους οφθαλμούς Composition based on Dictam against the bacterium Acanthamoeba that affects the eyes

Περιγραφή Description

Η σύνθεση μας βασίζεται στο Βότανο Δίκταμο το οποίο μετά από κατάλληλη επεξεργασία αναμιγνύεται με διάλυμα φύλαξης/συντήρησης φακών επαφής για την τελική μορφή του. Our formulation is based on the Dictamos Herb which, after appropriate treatment, is mixed with a contact lens storage/maintenance solution for its final form.

Το μικρόβιο Acanthamoeba είναι πολύ επικίνδυνο όταν προσβάλει τους οφθαλμούς προκαλεί λοίμωξη και μπορεί να προκαλέσει ακόμα και τύφλωση. Εμφανίζεται κυρίως σε φακούς επαφής και στους χώρους (κασετίνες) αποθήκευσης/συντήρησης αυτών. Η θεραπεία είναι δύσκολη και με άγνωστο ποσοστό επιτυχίας. The microbe Acanthamoeba is very dangerous when it infects the eyes it causes infection and can even cause blindness. It mainly appears in contact lenses and in their storage/maintenance areas (cases). Treatment is difficult and with an unknown success rate.

Πλεονέκτημα της εφεύρεσής μας είναι ότι η σύνθεσή μας δεν είναι χημική και δεν περιέχει φάρμακα, καθώς βασίζεται σε ένα βότανο που αναπτύσσεται σε βουνά της Κρήτης και έχει αποδεδειγμένα αποτελέσματα εξουδετέρωσης του μικροβίου, μετά από πειράματα σε εργαστήρια στην Σκωτία. The advantage of our invention is that our composition is not chemical and does not contain drugs, as it is based on an herb that grows in the mountains of Crete and has proven effects of neutralizing the microbe, after experiments in laboratories in Scotland.

Στο Σχήμα 1, αναφέρεται η μέθοδος και το αποτέλεσμα της μελέτης από Πανεπιστήμιο Σκωτίας, σχετικά με την αντιμετώπιση του βακτηρίου. In Figure 1, the method and the result of the study by the University of Scotland, regarding the treatment of the bacterium, is reported.

Χρησιμοποίησαν 2 τύπους του βακτηρίου (Acanthamoeba castellanii(70) και Acanthamoeba polYphaga(71)) με 5 εκχυλίσματα από Dictamo σε μια συγκέντρωση αποθεμάτων 100 mg/ml αντίστοιχα σε Dimethyl Sulfoxide. Τα φάρμακα αραιώθηκαν και χρησιμοποιήθηκαν για την ανίχνευση των 2 τύπων Acanthamoeba. 10 διπλές αραιώσεις έκαστου κλάσματος παρασκευάστηκαν εις τριπλούν διαμέσου της πλάκας και σε κάθε ένα προστέθηκαν 2χ105 (Α. Castellanii) και 8χ104 (A. Polyphaga) τροφοζωίτες που καλλιεργήθηκαν σε μέσο γλυκόζης Peptone στους 23 βαθμούς C. Οι πλάκες επωάστηκαν για 4 ημέρες και εκτιμήθηκε η βιωσιμότητα με την χρήση της δοκιμασίας Blue alamar(indicator for metabolic cell function). Τελικά αποδείχθηκε ότι το κλάσμα 4(fraction 4) είναι ποιο αποτελεσματικό να εξουδετερώνει τόσο το 70 όσο και το 71. They used 2 types of the bacterium (Acanthamoeba castellanii(70) and Acanthamoeba polYphaga(71)) with 5 extracts from Dictamo at a stock concentration of 100 mg/ml respectively in Dimethyl Sulfoxide. The drugs were diluted and used to detect the 2 types of Acanthamoeba. 10 two-fold dilutions of each fraction were prepared in triplicate across the plate and to each were added 2x105 (A. castellanii) and 8x104 (A. polyphaga) trophozoites cultured in glucose Peptone medium at 23 degrees C. The plates were incubated for 4 days and the viability using the Blue alamar (indicator for metabolic cell function) test. Finally, fraction 4 was shown to be the most effective at neutralizing both 70 and 71.

Σε υγρή μορφή, είναι ιδιαίτερα αποτελεσματική σε αυτούς που φορούν φακούς επαφής ή κολυμπούν σε πισίνες όπου ο κίνδυνος προσβολής είναι πολύ μεγαλύτερος. Για την καταπολέμηση της Acanthamoeba, το μόνο που χρειάζεται είναι η προσθήκη του διαλύματος μας τόσο στους φακούς επαφής όσο και στον χώρο συντήρησης αυτών. Αντιμετώπιση λοιπόν με φυσικό τρόπο, χωρίς παρενέργειες που συνήθως περιέχουν οι φαρμακευτικές αγωγές. Μπορεί να κατασκευαστεί σε διαφορετικές μορφές ανάλογα τις απαιτήσεις του εμπορίου π.χ. κρέμα ή σε διάλυμα υγρής μορφής. In liquid form, it is particularly effective for those who wear contact lenses or swim in pools where the risk of infection is much greater. To combat Acanthamoeba, all that is needed is the addition of our solution to both the contact lenses and the lens storage area. Therefore, treatment in a natural way, without side effects that usually contain pharmaceutical treatments. It can be manufactured in different forms according to the requirements of the trade e.g. cream or liquid solution.

Η εφεύρεση μας με βάση το Βότανο Δίκταμο χαρακτηρίζεται από την ανάμιξη του, τριμμένο σε μορφή σκόνης, με διάλυμα φύλαξης/συντήρησης φακών επαφής, σε αναλογία lmg σε 2 ml διάλυμα με 5% ποσοστό αυξομείωσης του βοτάνου με περίπου την ίδια αποτελεσματικότητα. Our invention based on the Dictamo herb is characterized by mixing it, ground into a powder form, with a contact lens storage/maintenance solution, in a proportion of lmg in 2 ml solution with a 5% percentage of the herb with approximately the same effectiveness.

Για ιδανική σύνθεση, προσθέτουμε 5mg Δίκταμο σε μορφή σκόνης σε 10ml διάλυμα φύλαξης/συντήρησης φακών επαφής και αναμιγνύουμε για το τελικό προϊόν. For an ideal formulation, add 5mg of Dictam in powder form to 10ml of contact lens storage/maintenance solution and mix for the final product.

Claims (2)

ΑΞΙΩΣΕΙΣ 1. Σύνθεση με βάση Βότανο Δίκταμο κατά του βακτηρίου Ακανθαμοέμπα χαρακτηρίζεται από την ανάμιξη του βοτάνου τριμμένο σε μορφή σκόνης, με διάλυμα φύλαξης/συντήρησης φακών επαφής, σε αναλογία lmg προς 2 ml, με ποσοστό αυξομείωσης των αναλογιών έως 5%.1. Composition based on the herb Dictam against the bacterium Acanthamoeba is characterized by the mixing of the herb, ground into a powder form, with a contact lens storage/maintenance solution, in a ratio of 1mg to 2ml, with a ratio of up to 5%. 2. Χρήση για την αντιμετώπιση όσων έχουν προσβληθεί από το βακτήριο Ακανθαμοέμπα.2. Use to treat those affected by the Acanthamoeba bacterium.
GR20180100568A 2018-12-27 2018-12-27 Ditanny-based composition against acanthamoeba bacterium affecting the eyes GR20180100568A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20180100568A GR20180100568A (en) 2018-12-27 2018-12-27 Ditanny-based composition against acanthamoeba bacterium affecting the eyes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20180100568A GR20180100568A (en) 2018-12-27 2018-12-27 Ditanny-based composition against acanthamoeba bacterium affecting the eyes

Publications (2)

Publication Number Publication Date
GR1009779B GR1009779B (en) 2020-07-06
GR20180100568A true GR20180100568A (en) 2020-07-16

Family

ID=71658147

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20180100568A GR20180100568A (en) 2018-12-27 2018-12-27 Ditanny-based composition against acanthamoeba bacterium affecting the eyes

Country Status (1)

Country Link
GR (1) GR20180100568A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1089745B1 (en) * 1998-06-18 2004-09-01 Biotics Research Corporation Oregano for the treatment of internal parasites and protozoa
WO2017094508A1 (en) * 2015-11-30 2017-06-08 ロート製薬株式会社 Ophthalmic composition
US9931428B2 (en) * 2011-06-13 2018-04-03 Oraldent Limited Ophthalmic compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1089745B1 (en) * 1998-06-18 2004-09-01 Biotics Research Corporation Oregano for the treatment of internal parasites and protozoa
US9931428B2 (en) * 2011-06-13 2018-04-03 Oraldent Limited Ophthalmic compositions
WO2017094508A1 (en) * 2015-11-30 2017-06-08 ロート製薬株式会社 Ophthalmic composition

Also Published As

Publication number Publication date
GR1009779B (en) 2020-07-06

Similar Documents

Publication Publication Date Title
Zakrewsky et al. Choline and geranate deep eutectic solvent as a broad‐spectrum antiseptic agent for preventive and therapeutic applications
Jang et al. Chlorpyrifos induces NLRP3 inflammasome and pyroptosis/apoptosis via mitochondrial oxidative stress in human keratinocyte HaCaT cells
Skeldon et al. The inflammasomes: molecular effectors of host resistance against bacterial, viral, parasitic, and fungal infections
BR112016006048B1 (en) ANTIMICROBIAL COMPOSITIONS
Lam et al. Interactions of Listeria monocytogenes with the autophagy system of host cells
van der Waal et al. Sodium chloride and potassium sorbate: a synergistic combination against E nterococcus faecalis biofilms: an in vitro study
Gupta et al. Development and characterization of polyphenon 60 and caffeine microemulsion for enhanced antibacterial activity
Siddiqui et al. Antiamoebic properties of salicylic acid-based deep eutectic solvents for the development of contact lens disinfecting solutions against Acanthamoeba
GR20180100568A (en) Ditanny-based composition against acanthamoeba bacterium affecting the eyes
Al-Adham et al. The antimicrobial activity of oil-in-water microemulsions is predicted by their position within the microemulsion stability zone
Zhylkibayev et al. Retinal injury mouse model and pathophysiological assessment of the effect of arsenical vesicants
Wylie et al. Development of a high-level light-activated disinfectant for hard surfaces and medical devices
DK173716B1 (en) Non-pharmaceutical composition containing a surfactant and a fluorine compound
US20200315956A1 (en) Compositions and methods for treating intervertebral discs
Popova et al. Investigation of the Action of the Anolyte after Different Storage Times on the Gram-negative Bacteria
US20090028839A1 (en) Compositions and methods for the prophylaxis and treatment of vaginal infections
Dąbrowska et al. Improved efficacy of eugenol and trans-anethole in combination with octenidine dihydrochloride against Candida albicans and Candida parapsilosis
Caires et al. Photoinactivation of mcr-1 positive Escherichia coli
Latifi et al. Comparing cytotoxicity and efficacy of miltefosine and standard antimicrobial agents against Acanthamoeba trophozoites and cyst forms: An in vitro study
Breikaa et al. Adverse testicular effects of Botox® in mature rats
Jakubowski et al. Sensitivity of antioxidant-deficient yeast Saccharomyces cerevisiae to peroxynitrite and nitric oxide
Gore et al. Efficacy assessment of a combined anticholinergic and oxime treatment against topical sarin‐induced miosis and visual impairment in rats
De Lima et al. Influence of photodynamic action on pure and mixed cultures of gram-negative bacteria: related to growth mechanisms
Okojie Biofilm Inhibition & Drug Synthesis
RU2664708C1 (en) Method of destroying and preventing formation of bacterial biofilms by complex of antimicrobial peptides of insects

Legal Events

Date Code Title Description
PG Patent granted

Effective date: 20200831